|25 July||Posting of Annual Report and Notice of AGM|
|10 July||Final Results for the year ended 31 March 2018|
|13 June||Notice of results for the year ended 31 March 2018
Analyst and investor briefing
|08 May||Collagen Solutions to Exhibit at 18th ESSKA Conference
"European Society of Sports Traumatology, Knee Surgery and Arthroscopy"
Dates: 9-12 May, SEEC, Glasgow
|03 May||Director / PDMR Dealing|
|11 April||Director / PDMR Dealing|
|10 April||Appointment of Chief Business Officer|
|06 April||Director / PDMR Dealing|
|04 April||Trading Update|
|28 March||Collagen Solutions Proposed Restructuring of New Zealand Operations to Pursue Tissue Opportunities|
|01 March||Collagen Solutions to Present at Canaccord Genuity Musculoskeletal Conference & Exhibit at American Academy of Orthopaedic Surgeons Conference|
|26 February||Hardman & Co Res: Nearing first proprietary product|
|22 February||Director/PDMR Shareholding|
|21 February||Positive Eight-Year Results of ChondroMimetic® Cartilage Repair Clinical Study|
|15 February||China Update|
|06 February||London Investor Symposium
Monday 26 February 2018
Qualified shippers ensure the product reaches its destination safely within client time and temperature protocols around the globe.
We will formulate a product specifically for your application.
Please contact us to discuss your requirements for collagen biomaterials.